Just read the IPO. my thoughts are scattered so I'll present my ideas on a pro/con basis. I'm a qualified molecular biologist but have little/no expertise in this field.
Cons-
CEO will be getting a ludicrous wage with relatively little skin in the game. A few performance shares in there for good measure but ~$400k pa plus bonuses is eye watering.
Cash burn is massive and this will need a CR quickly but that could be a pro which I'll discuss later
3D printing is miles off but the concept is there and I accept it as plausible and beneficial over existing technology. Only proven in mouse model as far as I can see.
Several things in the pipeline which could be seen as a bigger risk- I would prefer them to master profitability with one thing before pouring cash into another
Pros- BOD linked to other ASX hype stocks- UUV, DRO, NEA and KTD to name a few. Like most hype stocks they list just before a big piece of news which sends the SP flying in time for a CR.
Which leads me onto the fact that they expect a better version of the treatment to be ready this half. It will increase shelf life which will provide a wider area/more consumers to reach.
Currently only serving two hospitals. Increase that by one and you have 50% growth so potential for a bit of scale here with the new and improved treatment.
The treatment is at least as good or a better treatment to existing ones (IMO) once they can prove that with more studies then the potential for Medicare rebates, insurance etc opens up the potential to become a leader for the pancreatitis market.
Overall I like the concept of what they're currently doing and the idea of where they are trying to get to, but from a business perspective it's just another cash burning biotech hopeful. I wouldn't "invest" in this company per se however I can see the slightest whiff of hype with the 3D printing factor and it will send this thing flying. Overall a good speculative risk
to take for a ~6 month timeframe. I'm in for a penny. IMO only.
- Forums
- ASX - By Stock
- KOL
- Koligo IPO
KOL
koligo therapeutics limited
Koligo IPO, page-10
Currently unlisted. Proposed listing date: WITHDRAWN
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KOL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online